Crescent Grove Advisors’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,765
Closed -$325K 304
2025
Q2
$325K Hold
23,765
0.03% 209
2025
Q1
$365K Hold
23,765
0.04% 185
2024
Q4
$363K Sell
23,765
-3,135
-12% -$50.2K 0.04% 192
2024
Q3
$439K Hold
26,900
0.04% 177
2024
Q2
$506K Hold
26,900
0.06% 162
2024
Q1
$529K Buy
26,900
+7,557
+39% +$153K 0.06% 176
2023
Q4
$395K Hold
19,343
0.04% 201
2023
Q3
$389K Hold
19,343
0.05% 197
2023
Q2
$376K Hold
19,343
0.04% 207
2023
Q1
$363K Buy
19,343
+12,923
+201% +$257K 0.04% 211
2022
Q4
$132K Buy
6,420
+1,913
+42% +$38.5K 0.01% 270
2022
Q3
$81K Buy
+4,507
New +$91.7K 0.01% 254

Other funds holding OCSL

Crescent Grove Advisors's OCSL Position: Q3 2025 in Review

Crescent Grove Advisors sold out of Oaktree Specialty Lending (OCSL) in Q3 2025, closing a stake of 23,765 shares — an estimated $325K sold.

Crescent Grove Advisors first reported a position in OCSL in Q3 2022 and held it in 12 quarters. The position peaked at $529K in Q1 2024. 185 funds tracked by Wall St. Rank hold OCSL as of Q3 2025.

  • Crescent Grove Advisors reported no remaining Oaktree Specialty Lending position as of Q3 2025 after selling out during the quarter.
  • Crescent Grove Advisors sold 23,765 Oaktree Specialty Lending shares in Q3 2025, an estimated $325K.
  • Crescent Grove Advisors first reported a position in Oaktree Specialty Lending in Q3 2022 and held it in 12 quarters.
  • Crescent Grove Advisors's Oaktree Specialty Lending position peaked at $529K in Q1 2024.
  • 185 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q3 2025.

Based on Crescent Grove Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.